About Corneal Cross-Linking
To maintain the shape and strength of the cornea, our award-winning team at Vance Thompson Vision may advise corneal cross-linking to patients who present moderate to severe corneal thinning and/or keratoconus. Our doctors are committed to creating and protecting your vision, and they are delighted to offer corneal cross-linking as it was recently approved by the Food and Drug Administration (FDA). Vance Thompson Vision has been involved with corneal cross-linking since 2011 through our participation in the clinical trials leading up to FDA approval. We are now implementing this exciting technology and eager to continue developing and researching this treatment.
At our office in Omaha, NE, we see patients with advanced cases of irregularly shaped corneas, also known as ectasia, and we look forward to treating these patients as soon as possible. Corneal cross-linking, also known as CXL, is implemented to slow the progression of ectasia. CXL will not restore the cornea to its initial shape or correct poor vision. In treatment, we use a combination of ultraviolet light and riboflavin to form additional cross-links to stabilize the cornea.
What is ectasia? Patients who experience ectasia have devastating vision loss as the cornea bulges so much that the protrusions change the natural dome-like shape into a cone-like contour. At some point, the cornea will start to lose its strength since it is stretched beyond standard means. Vision in patients with ectasia will weaken as the cornea progressively weakens as well.
Corneal Cross-Linking Reviews
"My 13 year old son was diagnosed with bilateral keratoconus and needed crosslinking done in both eyes. We came to Vance Thompson after being diagnosed by another provider and they picked up his case and immediately began advocating for us. Insurance denied the procedure multiple times and they fought right alongside us to get the procedure approved. We had multiple setbacks in getting the procedure done and they went above and beyond to advocate, support and encourage us. The professionalism and compassion that was shown to use was outstanding. Words cannot express how thankful we are for this team and the services they provide."- M.Y. / Google / Aug 28, 2019
Best Candidates for Corneal Cross-Linking
An ideal candidate for CXL will have a diagnosis of ectasia, keratoconus, pellucid marginal degeneration, and any other disorder or disease that will lead to the thinning of the cornea. Patients with blurred or distorted vision, chronic eye irritation, or glare/light sensitivities may also be referred to our practice for a consultation as these conditions can be symptomatic of something wrong with the cornea.
Corneal Cross-Linking Treatment Options
While CXL is not a surgical procedure, it is still referred to as a minimally invasive treatment. During your diagnostic testing, your corneas will be mapped to detect deterioration and the level of severity of your condition. When you come into our office for your CXL procedure, you will lie on your back with an eye held open (one at a time) for the treatment. Riboflavin drops will be added to the eye while you are under ultraviolet light.
Advanced cases of ectasia will require the removal of the epithelium layer of the cornea to allow the liquid riboflavin to infiltrate within the corneal tissue. During treatment planning, your surgeon will discuss all your options for strengthening your cornea and how to manage your eye condition in the future, as CXL can be combined with other procedures for a more comprehensive treatment.
What to Expect with Corneal Cross-Linking
Your post-procedure aftercare is very important to your treatment. Please schedule and keep all follow-up appointments. You should watch for excessive swelling, irritation, pain, and/or infection in your eyes. Call our office immediately if you experience these symptoms.
- Recovery Time
- 3 - 4 days
- Procedure Time
- 1.5 hours
- Follow Up Time
- 3 days, 2 weeks, 1 month
- Recovery Location
Get Connected To Us
Having this sight-saving procedure may eliminate your need for a corneal transplant in the future. We invite you to connect with Vance Thompson Vision to learn more about how CXL can slow your progressive keratoconus or ectasis. Make your consultation appointment with us today in Omaha, NE.